Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S UMBERGER

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the American Veterinary Medical Association|August 1, 1992
Comparison of anthelmintic control programs for sheep in VirginiaA M Zajac, C D Thatcher, D Notter, et al.
Bioanalysis|November 15, 2022
Development of a selective, sensitive and robust oxyntomodulin dual monoclonal antibody immunoassayTara S Umberger, Wenyu Ming, Jennifer M Cox, et al.
Bioanalysis|December 24, 2014
Novel sandwich immunoassays for the measurement of total and active FGF21Tara S Umberger, John H Sloan, Jinbiao Chen, et al.
Plos One|November 19, 2013
Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lungTimothy R Holzer, Angie D Fulford, Drew M Nedderman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the American Veterinary Medical Association|August 1, 1992
Comparison of anthelmintic control programs for sheep in VirginiaA M Zajac, C D Thatcher, D Notter, et al.
Bioanalysis|November 15, 2022
Development of a selective, sensitive and robust oxyntomodulin dual monoclonal antibody immunoassayTara S Umberger, Wenyu Ming, Jennifer M Cox, et al.
Bioanalysis|December 24, 2014
Novel sandwich immunoassays for the measurement of total and active FGF21Tara S Umberger, John H Sloan, Jinbiao Chen, et al.
Plos One|November 19, 2013
Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lungTimothy R Holzer, Angie D Fulford, Drew M Nedderman, et al.
Pageof 1